These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT. MCNICOL GP; DOUGLAS AS Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517 [No Abstract] [Full Text] [Related]
5. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]
6. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response. Robertson BR Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287 [No Abstract] [Full Text] [Related]
7. [VALUE OF THROMBELASTOGRAPHY IN THERAPEUTIC FIBRINOLYSIS OBTAINED USING A NICOTINIC ACID DERIVATIVE]. PERRETTA A; PARANO JR; VILLA JJ Prensa Med Argent; 1964 Aug; 51():427-31. PubMed ID: 14193347 [No Abstract] [Full Text] [Related]
8. THROMBOSIS AND EMBOLISM. BEARD D Med J Aust; 1964 Sep; 2():452-5. PubMed ID: 14201724 [No Abstract] [Full Text] [Related]
9. PREVENTION OF CORONARY THROMBOSIS: CLINICAL OBSERVATIONS FOR 1 TO 10 YEARS. STERN ML Curr Ther Res Clin Exp; 1965 Mar; 7():195-203. PubMed ID: 14265008 [No Abstract] [Full Text] [Related]
11. [Effect of nicotinic acid on the fibrinolytic activity of the blood in atherosclerosis]. SHERSHEVSKII MG Kardiologiia; 1963; 3():64-8. PubMed ID: 13977201 [No Abstract] [Full Text] [Related]
12. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES]. PERICOLI F; NUZZI R Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994 [No Abstract] [Full Text] [Related]
13. Observations on the use of nicotinic acid to induce in vivo fibrinolytic activity. WILSON WL; FOSTIROPOULOS G Am J Med Sci; 1959 Nov; 238():591-7. PubMed ID: 13845147 [No Abstract] [Full Text] [Related]
14. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS. SHERSHEVSKII MG Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323 [No Abstract] [Full Text] [Related]
15. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY. CLIFFTON EE Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024 [No Abstract] [Full Text] [Related]
16. HYPERCHOLESTEREMIA: EFFECTS OF TREATMENT WITH NICOTINIC ACID FOR THREE TO SEVEN YEARS. CHRISTENSEN NA; ACHOR RW; BERGE KG; MASON HL Dis Chest; 1964 Oct; 46():411-6. PubMed ID: 14211853 [No Abstract] [Full Text] [Related]
17. [On the fibrinolytic and circulatory effect of nicotinic acid with special reference to its therapeutic usefulness]. EGLI H; KLENSCH H Med Welt; 1961 Oct; 41():2108-13. PubMed ID: 13889445 [No Abstract] [Full Text] [Related]
18. THE INFLUENCE OF AN INCREASED PLASMA FIBRINOLYTIC ACTIVITY ON THE PROTEIN PATTERN. BOGDANIKOWA B; BIELAWIEC M Sangre (Barc); 1964; 61():37-40. PubMed ID: 14214882 [No Abstract] [Full Text] [Related]
19. [On thrombolysis studies on the rabbit with combined nicotinic acid-heparin therapy]. SAILER S; EBER O Klin Wochenschr; 1960 Jun; 38():548-51. PubMed ID: 14440816 [No Abstract] [Full Text] [Related]
20. [On the problem of the thrombolytic effect of heparin and nicotinic acid]. Rasche H; Hiemeyer V Med Klin; 1968 Jan; 63(2):63-5. PubMed ID: 4175296 [No Abstract] [Full Text] [Related] [Next] [New Search]